PB2178: OUTCOMES OF REDUCED DOSE TEAM (THIOTEPA, ETOPOSIDE, CYTARABINE, MELPHALAN) PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANTATION FOR HODGKIN AND NON‐HODGKIN LYMPHOMA: A MONOCENTRIC EXPERIENCE.

Autor: Di Folca, S., Marafioti, V., barbato, S., Avilia, S., Grimaldi, F., Severino, A., Picardi, M., Luciano, L., Battipaglia, G., Pane, F.
Zdroj: HemaSphere; 2022 Supplement 3, Vol. 6, p2048-2049, 2p
Databáze: Complementary Index
Externí odkaz: